Randomized controlled clinical trial for the efficacy and safety of Kaihoujian inhalation for acute laryngitis

Wangjing Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Patients meets the standard of Western medicine acute laryngitis (light and moderate);
•(2) Patients meets the standard of Chinese medicine of wind-heat invading lung;
•(3) Aged 18 to 65 years;
•(4) Patients who first visit ENT clinicians within 48 hours;
•(5) Patients who signed the informed consent form.

•(1) Those with a body temperature higher than 37 degree C;
•(2) Those with common cold, influenza, acute tonsillitis, pharyngeal diphtheria, and Wensang's angina;
•(3) Those with acute tracheal-bronchitis, pneumonia, rheumatic fever , acute glomerulonephritis, rheumatic heart disease and other diseases;
•(4) Patients with severe primary diseases such as cardiovascular and endocrine or hematopoietic system and those with mental illness;
•(5) Patients with abnormal liver and kidney function tests, diabetes
•(6) WBC >= 1.2×10^9/L;
•(7) Pregnancy (defined as positive for pregnancy test), lactating woman or birth plan within half a year;
•(8) Accepted Chinese medicines or antibiotics who has similar efficacy in test drugs within 48 hours before enrollment;
•(9) Those who are participating in other drug clinical trials or known to be allergic to therapeutic drugs;
•(10) Those who believe that they are not suitable for the test;
•(11) Patients with obvious laryngeal mucosal edema by electronic laryngoscope.

发起方

Wangjing Hospital, China Academy of Chinese Medical Sciences